Department of Neurosciences, University of Padova, Padova, Italy.
Laboratoire d'Imagerie Biomédicale, Sorbonne University, CNRS, INSERM, Paris, France.
Eur J Neurol. 2019 Mar;26(3):519-524. doi: 10.1111/ene.13850. Epub 2018 Dec 7.
Literature data on spinal and bulbar muscular atrophy (SBMA) epidemiology are limited and restricted to specific populations. The aim of our study was to accurately collect information about SBMA patients living in the Veneto region in Italy to compute reliable epidemiological data. Androgen receptor (AR) lineages were genotyped to evaluate the presence of a founder effect.
A prevalence survey considering all SBMA patients diagnosed in the Italian Veneto region on 31 January 2018 was carried out. The presence of different haplotypes obtained genotyping 15 polymorphic markers (single nucleotide polymorphisms and short tandem repeats) around the AR gene was evaluated.
Based on 68 patients, the punctual prevalence of the disease on 31 January 2018 was 2.58/100 000 (95% confidence interval 1.65-3.35) in the male population. Five different haplotypes were identified, confirming the existence of multiple founder effects. It was also observed that, within the same haplotype, patients had a similar CAG repeat number (P-value < 0.001).
A reliable estimation of SBMA prevalence in the Italian Veneto region was calculated which does not seem to be affected by a strong founder effect. Moreover, our data suggest that the length of the CAG expansion could be preserved in patients harbouring the same haplotype.
有关脊髓和延髓肌萎缩症(SBMA)的流行病学文献数据有限,且仅限于特定人群。我们的研究旨在准确收集居住在意大利威尼托地区的 SBMA 患者的信息,以计算可靠的流行病学数据。雄激素受体(AR)谱系进行了基因分型,以评估是否存在创始效应。
对 2018 年 1 月 31 日在意大利威尼托地区诊断的所有 SBMA 患者进行了患病率调查。通过对 AR 基因周围的 15 个多态性标记(单核苷酸多态性和短串联重复序列)进行基因分型,评估了不同单倍型的存在。
基于 68 例患者,2018 年 1 月 31 日男性人群的疾病时点患病率为 2.58/100000(95%置信区间 1.65-3.35)。鉴定出五个不同的单倍型,证实了多个创始效应的存在。还观察到,在同一单倍型内,患者的 CAG 重复数相似(P 值<0.001)。
计算出意大利威尼托地区 SBMA 的可靠患病率,似乎不受强烈的创始效应影响。此外,我们的数据表明,携带相同单倍型的患者的 CAG 扩展长度可以保持不变。